Navigation Links
Malaria Vaccine - Render Powerless, the Parasite Behind the Host of Disease!

A disease that wipes out above one million people worldwide, of whom most are children- Malaria,// needs no introduction. The scourge, that has given sleepless nights to sufferers, health experts, and strategists worldwide, seems to have met its nemesis in the development of a novel vaccine that seeks to impede the growth of the parasite while it is relying on its host, the mosquito.

Work is gaining momentum on a malaria vaccine which is designed to hamper the development of the disease-causing parasite, during its stay in the mosquito’s body. The vaccine is equipped to aim at the Pfs25, a protein which is crucial to the parasite's development, while it is residing in the mosquito's gut. The antibodies from a vaccinated person will get passed on to the mosquito, when it bites a person, which would gain entry into the mosquito’s body and smother its growth.

The researchers are very hopeful of this vaccine as it is capable of completely wiping out malaria from many regions. But the vaccine may not be equipped to offset or reduce the impact of the disease in a vaccinated person. Many other types of malaria vaccines are in the pipeline, but none of them are legally permitted for use. Most of them are suited to deactivate the malaria parasite, Plasmodium, after it has entered the human body.

Dr Elias Zerhouni, director of the National Institutes of Health, said: "The experimental malaria vaccine shows great promise for combating a terrible disease that exacts a devastating toll on the world's children. Until now all other vaccines that have been developed have offered the individual some form of protection. In this case, the individual has got to make a sacrifice in order to protect the community, and that might make it very difficult to sell."


SA
'"/>




Page: 1

Related medicine news :

1. Malaria strikes Munger tribals
2. Sponging Cattle betters spraying in eradicating Malaria
3. Gene researchers make Malaria-resistant mosquito
4. More Treatment Options For Malaria
5. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
6. Jharkhand reports 13,000 Malaria cases
7. Researchers Discover Protein That Causes Malaria
8. Malarial gene ascertained
9. Artesunate Is Better For Malaria Than Quinine
10. New Strategies For Effective Treatment Of Malaria
11. Chloroquine and Primaquine combination Malarial drug for resistant parasites.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... ... August 16, 2017 , ... Modern Consulting Insurance & ... program. Partnering once again with Boys & Girls Clubs of Greater Kansas City, ... area’s very own American Idol. With all proceeds benefitting local worthy causes, donations ...
(Date:8/16/2017)... GA (PRWEB) , ... August 16, 2017 , ... ... for Telehealth, Inc. has received a three-year grant totaling $975,000, renewing its funding ... of Health and Human Services. , This funding marks, the fourth time the ...
(Date:8/16/2017)... ... August 16, 2017 , ... LabRoots , the leading provider of ... world, is excited to announce Andrew Ly as the winner of the LabRoots Summer ... costs. , Ly, who is in his third year at the University of ...
(Date:8/16/2017)... ... , ... With a new PD diagnosis every nine minutes, research is critical ... are awarded through a competitive application process and reviewed by APDA’s Scientific Advisory Board ... in all areas relevant to PD research. The SAB meets annually to review ...
(Date:8/16/2017)... ... August 16, 2017 , ... Melbourne’s reign as the world’s most liveable city ... (EIU) annual Liveability Index. , The Index surveys 140 of the world’s cities and ... Melbourne has consistently come in the top three of the index. So what is ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... , Aug. 7, 2017 Diplomat Pharmacy, Inc. ... Joel Saban as president, effective Aug. 7, 2017. ... has decided to pursue other interests and will serve ... his tenure, Paul has served us in multiple leadership roles ... Pharmacy in Jun. 2015 and has provided decisive, strategic leadership ...
(Date:8/7/2017)... -- Endo International plc (NASDAQ: ENDP ) today ... known U.S. mesh product liability claims and that it ... U.S. claims at reasonable values. Under the agreements, Endo ... of 2017 and continuing through the fourth quarter of ... the Company intends to increase its mesh product liability ...
(Date:8/4/2017)... 2017  Agragen, LLC, a Cincinnati ... biopharmaceutical, nutraceutical, and aquacultural feed sectors, announces a ... drug candidates, AGR131.  This drug is designed to ... blood of patients suffering from inflammatory conditions such ... Biological pharmaceuticals ...
Breaking Medicine Technology: